by Prof. Stephen L Archer MD, Queen’s University
Interested in advancing your drug discovery, pathobiological studies and diagnosis of COVID-19 as well as other progressive pulmonary diseases affecting lung microarchitecture? This webinar provides a comprehensive overview of research in Prof. Stephen Archer’s team, and a good example of their translational approach by incorporating in vivo imaging of mouse models using MILabs’ Micro-CT.
Took place: June, 2021 (at SNMMI MILabs Scientific Event)
You may also like
Each DNA damage repair pathway leads to the recruitment, upregulation, or activation of specific proteins within the nucleus, which, in some cases, can represent attractive targets for molecular imaging.
For a detailed biodistribution analysis, PET and SPECT are usually preferred as they are more accurate and quantitative, so the question is, can optical imaging become a complementary tool for pre-clinical biodistribution analysis.
Marko Rosenholm presents some of the findings and results regarding dynamic SPECT/CT imaging of a glymphatic system they have acquired with the MILabs VECTor/CT system.
